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The high affinity IgE receptor (FceRI) is a tetrameric 
hetero-oligomer composed of an a chain, a B chain, and 
two disulfide-linked y chains. The B chain contains four 
transmembrane (TM) segments and long cytoplasmic 
domains that  are thought to play an  important role in 
intracellular signaling. We now report the  structural 
characterization  and  the sequence of the complete hu- 
man B gene and cDNA. The gene spans -10 kilobases 
and contains seven  exons. There is a single transcrip- 
tion initiation  site preceded by a TATA  box. The  first 
exon codes for  the  5’-untranslated region and  a portion 
of the N-terminal cytoplasmic tail. TM-1 is encoded in 
exons 2 and 3, TM-2 in exons 3 and 4, TM-3 in exon 
6 ,  and TM-4 in exon 6. The seventh and  final exon 
encodes the end of the C-terminal cytoplasmic tail  and 
the 3’-untranslated sequence. The human B gene ap- 
pears to be a single copy gene. Two corresponding 
transcripts, detected as a doublet around 3.9 kilobases, 
are present in cells of mast cell and basophil lineage 
from  different individuals, but not in the  other hema- 
topoietic cells tested here. The human B protein is 
homologous to rodent 8. The consensus amino acid 
sequences of human, mouse, and rat B show 69% iden- 
tical residues. 
Analysis of the surface expression of transfected 
receptors indicates that human ay and a& complexes 
are expressed with comparable efficiency. Human @ 
interacts  with human CY more efficiently than does rat 
8, and both rat and mouse f l  interact  with  their  corre- 
sponding a more efficiently than does human 8, dem- 
onstrating a species specificity of the a/@ interaction. 
The high affinity IgE receptor (FctRI) is responsible for 
initiating the allergic response (1). Binding of allergen to 
receptor-bound IgE leads to cell activation and  the release of 
mediators (such as histamine) responsible for the manifesta- 
tions of allergy. This receptor is a tetrameric complex (aPy2) 
that is found on the surface of mast cells and basophils. The 
CY and @ subunits have not been detected in  other hemato- 
poietic cells (1, 2),  although the y chains of FceRI are found 
in macrophages (3), NK cells (4), and T cells (5 ) ,  where they 
associate with the low affinity receptor for IgG (FcyRIII)  or 
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with the T cell antigen receptor. 
Complementary DNAs have been isolated for the a (6-lo), 
p (ll),   and y (9, 12, 13) chains  in mouse, rat,  and humans. 
The genes for a and y both have been localized on human 
(14) and mouse (15, 16) chromosome 1. The gene for mouse 
@ has been localized on mouse chromosome 19 by genetic 
linkage and is thought  to be a single gene (16). The  structures 
of the a gene (rat) (17) and of the y gene (human) (13), but 
not of the /3 gene, have been characterized. 
The molecular cloning of the  subunits  has permitted the 
reconstitution of surface-expressed receptor complexes by 
transfection.  One of the surprising findings from these  studies 
was the differential  requirement for surface expression among 
the different species. Cotransfection of the  three chains (a, p, 
and y) is required to promote efficient surface expression of 
the  rat (12) or mouse (9) receptor. By contrast, surface expres- 
sion of the  human a y  complex can be achieved by cotrans- 
fecting a and y alone, suggesting that P is not necessary (18). 
This result (and our inability to clone human @) raised the 
interesting possibility that a y  complexes may exist  naturally 
in human cells. To address this question and  to study the 
possible regulation of human expression, we have isolated 
and characterized the human @ gene and cDNA. 
EXPERIMENTAL  PROCEDURES 
Screening of cDNA and Genomic Libraries-The human basophil 
cDNA library and  the human leukocyte genomic library have been 
described before (13). The human lung cDNA library (19) and a 
human skin cDNA library were kindly provided by Lawrence B. 
Schwartz (Medical College  of Virginia, Richmond, VA). 
The following probes were prepared for screening the various 
libraries: the EcoRI-EcoRV fragment of rat (3 (11) and  the EcoRI 
fragment of mouse (3 (9), both of which contain the entire coding 
sequence of /3 and  part of the 3’-untranslated region. Fragments of 
the coding region of rat (3 cDNA  (bp’  1-304) and of mouse p cDNA 
(bp 433-708)  were made by polymerase chain reaction (PCR). Mul- 
tiple oligonucleotides corresponding to various regions of rat, mouse, 
and human (3 were synthesized on  a Model 380A automated DNA 
synthesizer (Applied Biosystems, Inc., Foster City, CA).  All double- 
stranded DNA probes were radiolabeled by random primer labeling, 
and  the oligonucleotides by end labeling as described elsewhere (20). 
Hybridization and washing conditions and procedures for plaque 
purification, subcloning, sequencing, and DNA analysis were as de- 
scribed previously (13). 
cDNA  Synthesis  Using PCR-Basophils from 240 ml of blood  were 
purified by double Percoll gradients  as previously described (21), and 
basophil RNA was extracted by the guanidinium isothiocyanate 
method (20). Two fig of total RNA were reverse-transcribed with 
Superscript reverse transcriptase  (Bethesda Research Laboratories) 
using a random 9-mer primer as recommended by the manufacturer. 
One-twentieth of the reaction product was amplified using the follow- 
ing primers: a 23-mer complementary to nucleotides -2 to +21 of the 
human /3 coding sequence and, as backward primer, a degenerated 21- 
The abbreviations used are: bp, base pair(s); kb,  kilobase(s1; PCR, 
polymerase chain reaction; TM, transmembrane. 
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mer of the mouse and  rat 0 sequences starting 32 nucleotides after 
the  stop codon. Temperature cycles  were as follows: 1 cycle of 2 min 
at 95 "C, 2 min a t  94 "C, 5 min at 37 "C, and 40 min  at 72 "C; 4 cycles 
of 40 s a t  94 "C, 1 min a t  37 "C, 4 min a t  72 'C; and 36 cycles of 40 s 
at 94 "C, 1 min a t  50 "C,  and 4 min at 72 "C, followed by a single 15- 
min extension. One pl of this reaction was reamplified, omitting 
cycles 2-5, and  the amplification product was subcloned  into pCRlOOO 
using  the  TA cloning kit  (Invitrogen,  San Diego, CA). 
Direct  Sequencing of Gene Fragments Obtained by PCR-Purified 
insert-containingphage  DNA from the leukocyte  genomic library was 
linearized  with  NotI,  and  100 ng were  amplified with  primers  flanking 
the region to be sequenced. DNA  amplification was achieved using 
40 of the following cycles: denaturation for 1 min at 94 "C, annealing 
for 2 min at 45-50 "C, and  extension for 3-6 min at 72 "C. Subse- 
quently, 1 p l  of the amplified material was reamplified in three 
separate  reactions (50 p l )  under  identical  conditions,  omitting  one of 
the two primers  to  generate  single-strandedDNA.  The  three  reactions 
were  pooled, applied  to  an  Ultrafree MC 30.000 spin  column (Milli- 
pore, Bedford,  MA), and  washed  four  times before being  evaporated 
by vacuum. The  single-stranded  DNA was sequenced using  the  omit- 
ted  primer or an  internal  primer. Comparison of sequences  obtained 
by  this  method  or by sequencing nonamplified  fragments being sub- 
cloned  in  pGEM vectors  revealed no differences. 
Sequencing Transcription Start  Site-PCR  was  used to define the 
transcription start site. Procedures published elsewhere (22) were 
modified as follows. Five pg of RNA were reverse-transcribed as 
detailed above  using a primer  corresponding  to nucleotides +451 to 
429 of the coding region. The resulting product was washed on a 
Centricon 100 column (Amicon Corp., Beverly, MA), and poly(A) 
tails were added at both  ends using terminal  transferase  (Bethesda 
Research  Laboratories)  as recommended by the  manufacturer.  One- 
sixth of this  reaction was amplified  with the following two primers:  a 
33-mer consisting of the M13 primer sequence following by 17 T 
residues and, for the  3'  end, a primer derived from nucleotides  331 to 
308 of the  human 0 coding  region  sequence. Subsequently, an  internal 
amplification was performed exchanging  the  3'  primer for one equiv- 
alent  to nucleotides +189 to 169. Finally, single-stranded  DNA  was 
produced for sequencing using an oligonucleotide corresponding  to 
nucleotides 54 to 33 as the only primer.  For  all  PCRs,  the  annealing 
temperature was 45 "C, and  the  extension  time was 3 min. 
Analysis of Transcription Start Site by 5' Extension-An end- 
labeled  oligonucleotide corresponding to  the negative strand at nucle- 
otides 54 to 33 after  the  start codon  was  hybridized overnight a t  42 "C 
with  either 10 pg of total  RNA from enriched  basophils  (see above) 
or  10 pg of tRNA, followed by extension with Superscript reverse 
transcriptase a t  45 "C for 90 min. The  primer-extended  products were 
separated on urea 5% polyacrylamide gel in  parallel  with  the s quenc- 
ing  reactions of the genomic DNA. 
Other Methods-Northern and genomic Southern  blots were per- 
formed as described elsewhere (20). The various cDNAs were sub- 
cloned into the eukaryotic expression vector pCDL-SR(cr) for the 
transfection  studies (23). COS-7 cells were transfected by the  stand- 
ard  DEAE-dextran  method (24), except that  a 3-min  incubation of 
the transfected cells in 10% dimethyl sulfoxide in media  was added 
after  the chloroquine treatment. 
RESULTS AND DISCUSSION 
Isolation, Mapping, and Sequencing of Human FctRI p 
Gene-We first  attempted  to isolate human p cDNA clones 
by screening a  human  mast cell cDNA library with full-length 
rat  and mouse cDNA probes. These probes were radiolabeled 
and used to screen  7 x lo5 colonies. Four clones were isolated, 
all of which contained  a 153-bp insert with 73% homology to 
rat /3 cDNA. The sequence of this  insert corresponded to a 
portion of p that includes the intracellular loop and  the  third 
transmembrane domain. These four identical clones are the 
likely result of library amplification of a single clone generated 
by recombinations. We screened two additional libraries: an- 
other mast cell cDNA library and a cDNA library derived 
from basophil-enriched leukocytes. The latter library was 
used earlier to isolate human y cDNA clones. A total of IO7 
independent cDNA clones were screened with a panel of 
murine probes and oligonucleotides and with the 153-bp hu- 
man p probe. However, no  additional clones were isolated. 
We then screened 6 X lo5 independent genomic clones from 
a  human genomic leukocyte library with the radiolabeled 153- 
bp  human probe, and 10 clones with average size inserts of  25 
kb were isolated. These clones all hybridized with two 20-mer 
oligonucleotide probes corresponding to the beginning and 
the  end of the  rat (3 coding sequence. Four  different  restriction 
patterns could be generated from the 10 clones. However, 
Southern blots with various oligonucleotide probes scanning 
different regions of the  rat fi  coding sequence indicated that 
the four restricted patterns were not the product of different 
genes. Rather,  the clones showed differences in the lengths of 
the sequences flanking the ,B gene (data not shown). 
One clone containing  a 25-kb insert was chosen for further 
characterization, mapping, and sequencing. A  restriction map 
shown in  Fig. 1 was constructed 5y complete and incomplete 
digestions with the restriction endonucleases HindIII, PstI, 
BamHI, XbaI, SmaI,  and KpnI. A 3.2-kb HindIII fragment 
was found to hybridize with oligonucleotide probes corre- 
sponding to  the  start codon and  transmembrane regions I and 
I1 of rat 0. A 2.8-kb SmaI fragment hybridized with rat p 
probes of transmembrane regions I11 and IV, and a 4.5-kb 
SmaI fragment with probes of the stop codon region. The 
three fragments were subcloned into pGEMSzf(+) or-(-) and 
sequenced in full (Fig. 2). The fragment corresponding to  the 
0.9-kb gap between the  HindIII  and 2.8-kb SmaI fragments 
was produced by PCR  and sequenced. We also confirmed by 
PCR that the two SmaI fragments were adjacent to each 
other. 
By comparing the sequences of the  human /3 gene and of 
the rat p cDNA (Fig. 3), we localized seven homologous 
regions that may correspond to seven different exons. 
Synthesis of Human p cDNA Coding  Sequence-To confirm 
the sequence of the exons and to define the intron-exon 
borders, human /3 cDNA was synthesized by reverse transcrip- 
tion of RNA purified from basophil-enriched leukocytes, fol- 
lowed  by amplification of the reverse transcripts using PCR 
(described under  "Experimental Procedures"). This amplified 
product extended from two nucleotides preceding the  start 
codon to 32 nucleotides following the  stop codon. The cDNA 
sequence was found to be identical to the corresponding 
sequence of the  human p gene. This confirmed that  the coding 
sequence of human p is contained  in seven exons. Further- 
more, the comparison of cDNA and gene sequences and  the 
detection of consensus sequences for intron-exon borders in 
the  human gene allow for a precise determination of these 
borders. The  5' borders of the six intervening introns invari- 
ably start with GT,  and  the 3' borders end with AG. 
Analysis of Human p Transcripts-To evaluate the lengths 
of the 5'- and 3"untranslated sequences, we analyzed the size 
of human p transcripts. RNAs from basophil-enriched leu- 
kocytes obtained from different individuals were hybridized 
by Northern blotting with the radiolabeled 153-bp human /3 
. I - 1 kb 
FIG. 1. Structure of human fl  gene. Restriction  map  and  intron- 
exon structure are shown. The positions of the seven exons are 
depicted by boxes. The locations of the start and stop codons are 
indicated. 
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FIG. 2. Nucleotide sequence of hu- 
man FccRI B chain gene. The seven 
exons are shown in boldface type. The 
numbering of nucleotides is relative to 
the  start codon. The TATAA box, trans- 
lation  initiation codon (ATG), and ter- 
mination codon (TAA) and  the potential 
polyadenylation signals (AATAAA) are 
underlined. Bases that were not deter- 
mined with certainty  are denoted as N. 
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FIG. 3. Comparison of human B gene and rat 8 cDNA se- 
quences by dot matrix plot. The Pustell DNA matrix of the 
Macvector program was used with a window  of 30 nucleotides and a 
minimum score of 63%. The Roman numerals indicated on the left 
correspond to  the seven exons. 
probe (Fig. 4A). Two transcripts around 3.9 kb  were found in 
human basophils, but  not in COS-7 cells. The human tran- 
scripts are substantially longer than  their rodent counterparts 
(2.7 and 1.75 kb)  (9, 11) as detected in RBL  cells by cross- 
hybridization. This longer size may explain our failure to 
isolate human j3 cDNAs from the three oligo(dT)-primed 
libraries. Similar results were obtained with a full-length 
cDNA  probe of human j3 (data not shown). Hybridization of 
the same RNAs  with a human a cDNA probe  revealed tran- 
scripts for a of the expected size (1.1 kb) (Fig. 4B). RNAs 
from different cell lines were also  hybridized with a full-length 
human j3 cDNA probe  (Fig. 4C). The message  for human j3 
was only detected in the basophil line KU812, but not in 
U937, Daudi, and HeLa  cells.  An additional band was seen in 
KU812  cells that could  correspond to unspliced transcripts. 
With an open reading frame of 732 bp and assuming 200 
bp for the poly(A) tail, human j3 transcripts should contain 
-3 kb of untranslated sequences.  Fig. 3 shows that most of 
188- ms - 
FIG. 4. Presence of transcripts in basophils. Ten pg of t o t a l  
RNA from basophil-enriched leukocytes and various other cells were 
fractionated on  a  denaturing agarose gel before being transferred to 
Nytran membranes and hybridized with human 6 cDNA probes 
(nucleotides +306 to +456 in A and nucleotides -2 to +790 in C). 
The membrane shown in A was stripped and rehybridized with a full- 
length human CY cDNA probe ( B ) .  
the  untranslated sequences are in the seventh exon. We also 
explored the possibility that additional exons of 3’- or 5’- 
untranslated sequences  had not yet been  identified. 
Characterization of 5‘ End  and of Transcription Initiation 
Site-The transcription start site was determined by sequenc- 
ing directly a PCR-amplified product of the reverse-tran- 
scribed RNA as described under “Experimental Procedures.” 
RNA from basophil-enriched leukocytes was reverse-tran- 
scribed from a primer of the human j3 coding sequence. 
Poly(A) tails were added to the reverse transcripts by treat- 
ment with terminal transferase, and the resulting cDNAs 
were  amplified by PCR. Single-stranded DNAs (positive 
strands, poly(dT)-tailed) were then produced by asymmetric 
PCR and directly sequenced. The cDNA sequence of the 
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negative strand corresponding to  the 5' end of the RNA is 
shown in Fig. 5A and is compared to  the relevant sequence of 
the @ gene. The perfect match between the two sequences 
ends  after GGGTT. Then,  the cDNA sequence reproducibly 
shows a  C residue, which is not present  in the gene,  followed 
by  the expected poly(A) tail. This additional  C residue could 
correspond to  the G residue of the cap structure  and indicate 
the location of the start site. 
Experiments of 5' extension (Fig. 5B) confirmed that  there 
is a major start  site in this area (-11 nucleotides 3' of the 
position described above), although it is difficult to exclude 
the possibility that  the  faint  bands seen below and above the 
major start  site could correspond to minor start sites. How- 
ever, the presence of a TATAAA box found  in the 5' sequence 
supports  the existence of a unique start site. In addition, the 
location of the TATAAA  box (usually 25 nucleotides 5' of the 
start  site) is more consistent with the precise localization of 
the  start  site  as shown in Fig. 5A. Indeed, the TATAAA  box 
is located between nucleotides 29 and 24 upstream of this 
start site. Taken together, our data indicate that  the human 
,f3 mRNA starts with the sequence AACCC (see Figs. 2 and 
5A) and  has 102 bp of 5"untranslated sequence. 
Characterization of 3' End-A comparison between the  rat 
p cDNA and human @ gene sequences (Fig. 3) shows that  the 
seventh exon of the @ gene extends from a t  least nucleotide 
6773 to  at least nucleotide 8910. But,  an additional 3'-un- 
translated sequence (-800 bp) had  to be found to fully account 
for the 3.9-kb transcripts. To analyze whether the missing 
sequence was part of the seventh exon or of other undetected 
exons, we prepared three probes from the @ gene to  test  their 
reactivity with @ transcripts. These  transcripts hybridized on 
Northern blots with both the NsiI-BamHI  fragment (nucleo- 
tides 8460-9250) and  the BamHI-SphI  fragment (nucleotides 
9250-9714), but  not with the fragment 3' of the  SphI  site 
(data  not shown). Interestingly, two polyadenylation signals 
(AATAAA)  were found at  nucleotides 9663 and 9758 (Fig. 2). 
Therefore, this region is likely to correspond to  the  end of 
exon 7. We suggest that both polyadenylation signals could 
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FIG. 5. Determination of transcription initiation site. A, 
RNA from  basophils  was  reverse-transcribed,  poly(A)+-tailed a t  both 
ends with terminal  transferase,  and amplified by PCR. The amplified 
product  (cDNA)  and  the genomic DNA (gene) were sequenced  with 
an  identical primer,  and  the respective sequencing  reactions were run 
in parallel  on a 8% acrylamide gel. The arrow marks  the  transcription 
start  site. B,  RNA from basophils (law I )  or  tRNA ( l a n e  2) was  used 
in  the primer  extension (PE), and  the  extended  products were ana- 
lyzed on a urea-5%  polyacrylamide gel in parallel with  the sequencing 
reactions of the genomic DNA. The arrow marks  the  transcription 
start  site. 
be used to create the  apparent doublet of transcripts around 
3.9 kb (see Fig. 4). 
Organization of Human @ Gene-Taken together, our data 
indicate that  the  human @ gene contains seven exons and six 
introns  and  spans -10 kb. Exon 1 codes for 102 bp of 5'- 
untranslated sequence and  the first 18 amino acid residues of 
the N-terminal cytoplasmic tail. Exon 2 encodes the remain- 
ing of the cytoplasmic tail  and  the first  3 residues of TM-1. 
Exon  3 codes for the remainder of TM-1, the first extracellular 
loop, and  the first half of TM-2. Exon 4 encodes the second 
half of TM-2  and a  portion of the cytoplasmic loop. Exon 5 
codes for the  last 3 residues of the cytoplasmic loop, TM-3, 
and most of the second extracellular loop. Exon 6 codes for 
the  last 2 residues of the extracellular loop, TM-4, and  the 
first  quarter of the C-terminal cytoplasmic tail. Finally, exon 
7 codes for the remainder of the cytoplasmic tail  and  the long 
3"untranslated sequence. 
Southern Blot Analysis-Digestion of genomic DNAs from 
five different individuals with BamHI, BglII, EcoRI, HindIII, 
MspI, and  PuuII  and hybridization of these digests with a 
human cDNA probe (from start  to  stop codon) support the 
existence of a unique gene (Fig. 6). In addition, the lengths of 
the restriction  fragments detected on the  Southern blot are 
entirely consistent with the lengths predicted from the se- 
quence of the gene. Three BamHI  sites (nucleotides 156,6908, 
and 9250) are present in the gene. As expected, only one 
fragment (nucleotides 156-9250) is seen here because the 
other fragments  should not hybridize with the cDNA  probe. 
The two predicted BglII fragments (nucleotides +334 to +1766 
and +1766 to +7419) and  the two predicted HindIII fragments 
(nucleotides -454 to +2724 and +2724 to 100,042)  were 
readily detected. The results  obtained after EcoRI and  PuuII 
digestions are consistent  with the fact that none of these  sites 
are found in the sequence of the gene. Finally, the  pattern 
observed after MspI digestion is also consistent with predicted 
fragments of 2067 and 3870 bp and a larger 5' fragment 
extending from nucleotide 3622 to  an undetermined MspI site 
upstream of the gene. 
Human @ Protein-The human @ protein comprises 244 
amino acids residues and  has a molecular mass of  26,532  Da 
(Fig. 6). Like rat (243 amino acids) and mouse (236 amino 
acids) @, human @ contains four hydrophobic segments sugges- 
tive of transmembrane domains, but no leader peptide. Fig. 7 
shows an alignment of the human sequence with the  rat  and 
mouse sequences. The consensus sequence for @ (data not 
shown) from the  three species (rat, mouse, and human) shows 
that 91.4%  of the amino acid residues are homologous, 
whereas 68.7% are identical. 
Transfection in COS-7 Cells: Expression of Human and 
Hybrid FctRI Receptors-We have shown previously that 
cotransfection of a, @, and y cDNAs is necessary to promote 
expression of rat  or mouse FccRI on  the surface of transfected 
COS-7 cells (12). By contrast, cotransfection of human CY and 
y cDNAs results  in the surface expression of cuy complexes 
without apparent need for @ (18). With the availability of 
human @ cDNAs, we analyzed whether human @ would influ- 
ence in  any way the efficiency of surface expression of the 
human receptor complex. Table  I shows that cotransfection 
of human cu and y cDNAs into COS-7 cells resulted in 10.4 f 
8.7%  of the cells being fluorescent when analyzed by fluores- 
cence-activated cell sorting after binding of fluoresceinated 
IgE. This level of expression was not significantly modified 
when human @ cDNA was cotransfected with human cu and y 
cDNAs (8.3 & 5.0%). Thus, human @ does not seem to influ- 
ence the level of surface expression of human FccRI in trans- 
fected COS-7 cells. Substituting rat @ for human @ had a 
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FIG. 6. Southern blot analysis of 
genomic DNAs obtained from five 
different individuals. The DNAs were 
subjected to distinct  restriction  endonu- 
clease digestions, blotted,  and hybridized 
with  the  human full-length cDNA. The 
numbers  on  the  top  indicate  the  different 
individuals, whereas each panel corre- 
sponds  to a different restriction digest. 
Size  standards  are  indicated  on  the  right 
(in kilobases). 
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TABLE I 
Functional expression of FccRI after  transfection of various 
subunit  combinations 
Fluorescent  cells 
(FACSY 
n Mean * S.D. 
Transfected cDNAs 
% 
Human a - - 1 0.2 
Human a human @ - 1 0.2 
Human a - human y 7 10.4 f 8.7 
Human a human@  human y 7 8.3 f 5.0 
Human a rat @ human y 4 5.4 f 3.4 
Rat a rat @ rat y 8 18.0 f 17.8 
Rat a human @ rat  y 10  2.4 f 2.0 
Rat a human @ human y 5 1.8 f 1.3 
Mouse a mouse @ mousey 4 8.2 f 5.6 
Mouse a human @ mousey 6 1.6 f 1.2 
Mousea  human@  human y 2 1.5f 0.8 
Human a - 
Human a rat @ 
rat ytmne 7 1.4 f 1.0 
rat ytmnc 5 3.2 f 2.8 
Human a human @ rat ytmnc 7 7.4 f 7.9 
Rat a rat @ 
Rat a 
rat ytmnc 2 9.3 f 0.8 
human B rat  Y~~~~~ 2 0.4 f 0.5 
FACS, fluorescence-activated cell sorting; trunc,  truncated. 
tendency to reduce the level of expression (5.4 f 3.4%), 
although that difference is not statistically significant. 
We then analyzed the effect of substituting  human j3 for 
rat j3. Cotransfection of rat a, j3, and y cDNAs resulted in a 
much higher level of expression (18.0 f 17.8%) than cotrans- 
fection of rat a and y with human j3 (2.5 f 2.0%) (Student's 
t statistic, 2.75; p 5 0.014). Similarly, cotransfection of mouse 
a, j3, and y cDNAs was more efficient (8.2 f 5.6%) than 
cotransfection of mouse a and y with human j3 (1.6 f 1.2%) 
(Student's t statistic, 2.91; p 5 0.019). Since replacing rat y 
or mouse y with human y did not restore expression (compare 
80 
80 
12 
162 
161 
153 
244 
243 
235 
FIG. 7. Amino acid sequence of 
human FccRI @ subunit and align- 
ment with rat and mouse @. Identical 
and  nonidentical  amino acid  residues are 
indicated by upper- and lower-case let- 
ters, respectively. The  identities  and 
closely related exchanges are indicated 
by carets in  the query  line,  whereas the 
distantly  related exchanges are  denoted 
by dots. Nonhomologous  exchanges  show 
no  marking  in  the  query line. Gaps  are 
indicated by dashes. The  transmem- 
brane domains are underlined, and  the 
splice sites  are indicated by vertical bars. 
2.4 with 1.8% and 1.6 with  1.5%), it is likely that  the problem 
in expression resides in the  human j3/rat a or human B/mouse 
a interaction. 
It is known that  truncation of the cytoplasmic tail of rat y 
prevents the surface expression of human a in transfectants 
(25). We therefore  tested  whether  human j3 could complement 
for the surface expression of human a under  these conditions. 
We first confirmed that cotransfection of human a with 
truncated  rat y permitted only very poor surface expression 
of ay complexes (1.4 & 1.0%). When  human j3 was cotrans- 
fected with the  latter combination, there was an increase in 
expression (7.4 f 7.3%, n = 7), although it is not statistically 
significant. However, this increase did become significant ( p  
5 0.035) when one aberrant point was not included in the 
seven experiments. The same increase was not observed when 
rat j3 was substituted for human j3 (3.2 f 2.8%), suggesting 
again that  there may  be specific points of interaction between 
human a and j3. In  other experiments using truncated rat y, 
we found that human j3 could not be  substituted for rat j3 in 
its interaction with rat a (compare 9.3 f 0.6 with 0.4 f 0.4%) 
(Student's t statistic, 13.0; p 5 0.006). 
Taken together,  these data indicate that there is a tendency 
for human j3 to  interact more efficiently with human a than 
does rat j3, but  the species specificity is weak. By contrast, 
there is a strong species specificity in  the interaction between 
rat j3 and a or between mouse j3 and a. 
As shown previously (18) and again here, human ay com- 
plexes can  be expressed on the surface of transfected cells. 
Moreover, cotransfection of human a and y with rat j3 results 
in only 20% of the receptors being aj3y complexes, with the 
remaining 80% being ay complexes (18). Therefore, it is 
theoretically possible that ay complexes occur naturally. 
However, in view of the species specificity of interaction 
between human j3 and a (see above), our previous results 
Gene for the p Subunit of FctRI 12787 
obtained from the cotransfection of human a and y with rat 
@ may not reflect the in uiuo situation. Nevertheless, it is still 
possible that a certain proportion of ay complexes are ex- 
pressed on the surface of @ positive basophils and  mast cells. 
We are presently attempting  to generate an antibody specific 
to human fi  to address this possibility. 
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